Experts Weigh In On Zocor "Pharmacy Status" In U.K., Prospects For U.S. Statin Switch
This article was originally published in The Pink Sheet Daily
Executive Summary
Four experts in cardiovascular medicine participated in interviews with "The Tan Sheet" to discuss the U.K.'s decision to switch Merck's cholesterol-lowering drug simvastatin 10 mg behind-the-counter.